MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS earnings per share and revenue

0A9G earnings per share for the last semiannual are -0.02 USD whereas the estimation was -0.04 USD which accounts for 47.65% surprise. Company revenue for the same period amounts to 1.45 M USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next semiannual are -0.01 USD, and revenue is expected to reach 25.00 M USD. Also watch annual changes over time to get a bigger picture of 0A9G earnings per share and revenue dynamics.